Results 221 to 230 of about 27,161 (265)

Real-world landscape of drug-related ocular injuries: a retrospective pharmacovigilance study. [PDF]

Front Pharmacol
Li G, Song Z, Li S, Wang J.
europepmc   +1 more source

Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system. [PDF]

PLoS One
Ge D, Wu L, Yang J, Sun J, Wang J, Wang J, Song H, Wei R, Xu Z, Zhao B, Sun R, Wang Y.   +11 more
europepmc   +1 more source

Hand-foot skin reaction associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a FAERS-based pharmacovigilance study. [PDF]

Front Med (Lausanne)
Chen J, Xu Q, Wang B, Sun H, Shu Q.
europepmc   +1 more source

Respiratory drugs and psychiatric adverse events in children and adolescents: a pharmacovigilance study based on the FAERS database. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Feng J, Zhao S.
europepmc   +1 more source

A pharmacovigilance study of Bruton's tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase. [PDF]

Front Immunol
Qu H, Jia Y, Liu Z, Li Z, Zhao X, Wu Z, Fan G, Lou Y.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tramadol‐induced hypoglycemia: A pharmacovigilance study

Fundamental & Clinical Pharmacology, 2021
AbstractSeveral papers have reported that tramadol can induce hypoglycemia. However, in some reports, confounding factors can be found, like coadministration of hypoglycemic drugs. We used the WHO pharmacovigilance database (VigiBase®) to investigate whether tramadol alone could be associated with hypoglycemia.
Claire De Canecaude, Vanessa Rousseau, Agnès Sommet, Jean‐Louis Montastruc   +3 more
openaire   +2 more sources

Amiodarone and Parkinsonism: a pharmacovigilance study

Fundamental & Clinical Pharmacology, 2020
AbstractBackgroundSome case reports have described parkinsonism with amiodarone. We investigated a putative association between parkinsonism and exposure to amiodarone.MethodsWe used the WHO pharmacovigilance database (VigiBase®). All adverse drug reactions with ‘Parkinson‐like events’ and amiodarone were included. Four disproportionality analyses were
Jean‐Louis Montastruc, Geneviève Durrieu   +1 more
openaire   +2 more sources

Antipsychotics and risk of QT prolongation: a pharmacovigilance study

Psychopharmacology, 2022
While meta-analyses of clinical trials found that lurasidone and partial dopamine agonists (brexpiprazole and aripiprazole) were the antipsychotics less likely to cause QTc prolongation, and sertindole, amisulpride, and ziprasidone were the most frequently associated with this adverse drug reaction; no real-world studies have investigated this risk ...
Bordet, Constance, Garcia, Philippe, Salvo, Francesco, Touafchia, Anthony, Galinier, Michel, Sommet, Agnes, Montastruc, Francois   +6 more
openaire   +2 more sources

Pharmacovigilance study of alendronate in England

Osteoporosis International, 2003
Alendronate sodium is an aminobiphosphonate, an analog of inorganic pyrophosphate, indicated for the treatment of osteoporosis in post-menopausal women. We analyzed events reported in patients prescribed alendronate by general practitioners (GPs) in England.
Pipasha N, Biswas, Lynda V, Wilton, Saad A W, Shakir   +2 more
openaire   +2 more sources

Ondansetron induced blindness: a pharmacovigilance database study

Expert Opinion on Drug Safety, 2023
Ondansetron is an antiemetic drug (AED) used to prevent and treat nausea and vomiting. The summary of product characteristics reports a rare risk of transient blindness primarily during IV injections, notably with the concomitant use of chemotherapeutic agents.
R. Barus, C. Potey, S. Gautier, G. Wabont   +3 more
openaire   +3 more sources